Neuland Laboratories logo

Neuland Laboratories results

NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap

Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.

52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
Market cap
₹24,204 Cr356th largest listed
P/E
48.6
P/B
12.9
Dividend yield
0.18%
ROE
29.3%
ROCE
32.1%
Debt to equity
0.10
Volume, NSE
53,34748.3% delivered

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Neuland Laboratories annual results and balance sheet

Revenue
₹642 Cr+119.2% on a year ago · −17.3% on the quarter before
Operating profit
₹223 Cr+546.3% on a year ago · −27.5% on the quarter before
Net profit
₹148 Cr+962.4% on a year ago · −30.6% on the quarter before
Earnings per share
₹115.10+962.8% on a year ago · −30.6% on the quarter before
Operating margin
34.7%
Net margin
23.0%

From revenue to net profit, ₹ crore

  1. Revenue642
  2. Materials and goods−221
  3. Employee costs−106
  4. Other expenses−91
  5. Operating profit223
  6. Depreciation−27
  7. Other income+8.5
  8. Finance costs−7.0
  9. Profit before tax198
  10. Tax−50
  11. Net profit148

Neuland Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 29 OctDec 2021Q3Filed 1 FebMar 2022Q4Filed 12 MayJun 2022Q1Filed 3 AugSep 2022Q2Filed 11 NovDec 2022Q3Filed 16 FebMar 2023Q4Filed 17 MayJun 2023Q1Filed 3 AugSep 2023Q2Filed 8 NovDec 2023Q3Filed 9 FebMar 2024Q4Filed 11 MayJun 2024Q1Filed 2 AugSep 2024Q2Filed 6 NovDec 2024Q3Filed 10 FebMar 2025Q4Filed 10 JunJun 2025Q1Filed 31 JulSep 2025Q2Filed 7 NovDec 2025Q3Filed 9 FebMar 2026Q4Filed 12 MayJun 2026Q1Filed 5 Aug
Revenue from operations258236256221294269407363418393385440311398328293514440776642
215204217193224215287266280272278316249311277258359363469419
Materials and goods bought11310611889111106173146152142138177117166127114184189269221
Employee costs47484448525250606966627363696673808998106
Other expenses55505556615864615964786668768471958510191
Operating profit before depreciation433239296954120971371211071236287513415677307223
Operating margin16.6%13.7%15.2%12.9%23.6%20.1%29.4%26.7%32.9%30.9%27.8%28.1%20.0%21.8%15.6%11.8%30.2%17.5%39.6%34.7%
Depreciation and amortisation1213121313131314151516161616172023242527
Other income021101823255447828128
Finance costs43333342444312255777
Profit before one-off items and tax28182413533911083122104921094972391812954287198
One-off items0000000000021056000000
Profit before tax281824135339110831221049213049128391812954287198
7523158262132232532172611433147550
Tax rate26.1%29.1%10.3%26.0%27.7%21.5%23.3%25.6%26.6%22.1%26.7%24.6%33.5%20.5%29.2%20.9%25.2%25.5%26.0%25.4%
Net profit2013221038318562898168983310228149741213148
Other comprehensive income−40−210−2−20001000000010
Total comprehensive income1713201138298262908168983310228149740214148
Net margin7.9%5.5%8.5%4.5%13.1%11.3%20.8%17.0%21.4%20.7%17.5%22.3%10.6%25.5%8.5%4.7%18.8%9.2%27.4%23.0%
Earnings per share₹15.88₹10.08₹17.01₹7.77₹29.97₹23.81₹65.90₹48.23₹69.56₹63.44₹52.66₹76.28₹25.60₹79.18₹21.67₹10.83₹75.49₹31.62₹165.76₹115.10
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each

16 earlier filings